Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Biochim Biophys Acta. 2015 Sep 12;1850(12):2422–2438. doi: 10.1016/j.bbagen.2015.09.007

TABLE 3.

A summary of the receptors that endostatin binds to and its subsequent effects.

Location Effects of Endostatin Binding References
Receptor
VEGFR-2 (flk-1/KDR) Blood vessel and lymphatic vessel surface Inhibits angiogenesis by competitively inhibiting VEGFR-2.
Prevents VEGF-C induced ERK/p38/MAPK signaling cascade.
Pedram et al. [101]
Kim et al. [102]
VEGFR-3 (flt-4) Lymphatic vessel surface Inhibits lymphangiogenesis via direct and indirect mechanisms. Han et al. [104]
Integrin α5β1 Cell surface Disrupts cell migration.
Causes integrin α5β1 to cluster and associate with caveolin-1.
Causes phosphorylated Src to associate with caveolin-1 and disrupt focal adhesion factor and actin stress fibers.
Hypothesized to prevent mast cells from binding to fibronectin.
Wary et al. [113]
Gille et al. [135]
Rehn et al. [108]
Wickstrom et al. [111]
Sudhakar et al. [107]
Morais et al. [112]
Brideau et al. [136]
Integrin αVβ3 Cell surface Inhibits angiogenesis.
Hypothesized to prevent mast cell from binding to vitronectin.
Rehn et al. [108]
Brideau et al. [136]
Glypican-1 and -4 Blood vessel surface Binding is necessary for endostatin to bind to its high-affinity receptor to elicit anti-angiogenic effects via unclear mechanism. Karumanchi et al. [114]
Reis et al. [116]
Cell Surface-Associated Protein
Thrombospondin-1 ECM Upregulates thrombospondin-1 expression Abdollahi et al. [119]
Faye et al. [117]
SPARC ECM Unknown mechanism. Abdollahi et al. [119]
Faye et al. [117]
Endorepellin Blood vessel surface Endorepellin inhibits endostatin’s anti-angiogenic activities, but carries out its own anti-angiogenic properties. Miosge et al. [121]
Mongiat et al. [120]
Transglutaminase-2 Blood vessel surface Unknown mechanism. Dardick [125]
Faye et al. [117]
Faye et al. [123]
Biglycan ECM Prevents biglycan LDL retention and atheroma formation. Zeng et al. [127]
Amyloid Peptide Brain Implicated in Alzheimer’s disease. Deininger et al. [128]
Kranenburg et al. [129]
Faye et al. [117]
Nucleolin Nucleolus Inhibits cell migration and tube formation. Srivastava et al. [137]
Huang et al. [132]
Shi et al. [134]